Concerns are continuing to grow in Asia over AstraZeneca’s COVID-19 vaccine. The Philippines and South Korea have suspended its use for those under 60. At the same time, Europe is still weighing up the risks of the vaccine after British and EU regulators found possible links between the jab and very rare cases of blood clots. However, the European Medicines Agency insists the benefits outweigh the risks.
Subscribe to our channel here: https://cna.asia/youtubesub
Subscribe to our news service on Telegram: https://cna.asia/telegram
CNA Lifestyle: http://www.cnalifestyle.com